Veritiv secondary offering
Davis Polk advised the underwriter in connection with an SEC-registered secondary offering of 1,400,000 shares of Veritiv Corporation’s common stock by UWW Holdings, LLC. The common…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Morgan Stanley restarts financing and structured product programs
Davis Polk advised Morgan Stanley on the recommencement of its SEC-registered financing programs and the related filing of its universal shelf registration statement, which includes a…
Pacific Gas and Electric $1.45 billion first mortgage bonds offering
Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering by Pacific Gas and Electric Company of $1.45 billion aggregate…
NatWest Group £1 billion contingent convertible additional Tier 1 capital notes
Davis Polk advised NatWest Group plc, a public limited company incorporated under the laws of Scotland, in connection with its SEC-registered shelf takedown of £1 billion aggregate…
AngloGold Ashanti $700 million debt offering
Davis Polk advised the underwriters in connection with an SEC-registered offering of $700 million aggregate principal amount of 3.750% notes due 2030 by AngloGold Ashanti Holdings plc,…
Soltec Power Holdings €150 million IPO
Davis Polk advised Soltec Power Holdings, S.A. on the Rule 144A/Regulation S initial public offering by Soltec Power Holdings of 31,146,717 of its ordinary shares. The initial public…
Delek Group $180 million senior secured project notes offering
Davis Polk advised Delek Overriding Royalty Leviathan Ltd., on its Rule 144A offering of $180 million principal amount of 7.494% senior secured notes due 2023. The notes are secured by…
Hubei Science & Technology Investment Group $300 million bonds offering
Davis Polk advised the underwriters in connection with a Regulation S offering by Hubei Science & Technology Investment Group (Hong Kong) Company Limited, a wholly owned subsidiary of…
Xspray Pharma SEK 265 million private placing of new shares
Davis Polk advised Xspray Pharma AB (publ) on a private placing of new shares. The private placing raised gross proceeds of approximately SEK 265 million.
Xspray was founded in 2003…
Celonis acquisition of Integromat
Davis Polk advised Celonis SE on its acquisition of Integromat s.r.o. Financial terms of the transaction were not disclosed.
Celonis, headquartered in Munich and New York, is a market…